March 2021
      Back to home
      1. Knowledge Base
      2. Latest News
      3. March 2021

      COVID-19 Vaccinations - Customer Update (10th March 2021)

      As you will be aware, the rollout of the COVID-19 vaccination is now taking place across the UK. We have been working closely with each national body and we would like to share with you the following update on our progress and short term implementation plans:

      Receiving Vaccinations and Adverse Reaction Data

      Federations, Clusters and Primary Care Networks - All Countries

      If your Federation/Primary Care Network/Cluster is going to be involved in the national COVID vaccination programme, please can you use one of the national recommended systems for recording COVID vaccinations. This request is based on national guidance issued. This is to allow for consistent data capture and central reporting to take place via existing messaging solutions.
      We are working with each national body to receive this data automatically into the patient's record.

      Practices

      England, Wales & Northern Ireland

      It is understood that initially, the majority of COVID-19 immunisations will be administered to the general population via mass vaccine centres in England and Wales. Vaccine and adverse reaction data will be electronically recorded on site using systems selected by national bodies (Pinnacle, Sonar and System C for England and WIS for Wales). The write back of this data to Vision 3 will be implemented in a similar way to the shielded patient lists, whereby Cegedim Healthcare Solutions will be issued with the data from national systems and we will regularly update your patient records with the relevant information.

      Note - Adverse reaction data will not be sent by national bodies at the current time and will not be available for viewing in the patient record.

      Scotland

      It is understood that initially, the majority of COVID-19 immunisations will be administered to the general population via general practice vaccination clinics and mass vaccine centres in Scotland. Vaccine and adverse reaction data will be electronically recorded on site using systems selected by national bodies. The write back of this data to the patient record is also being managed by a nationally selected third party tool. Please contact your local Health Board with any queries.

      All Countries - Vision 3 - Recording Vaccinations

      SNOMED version 31.1 has been released to all practices in the UK. This delivers the following new COVID-19 vaccination terms:

      • 65F0100 Administration of first dose of severe acute respiratory syndrome coronavirus 2 vaccine (procedure)(SNOMED CT Concept 1324681000000101)
      • 65F0200 Administration of second dose of severe acute respiratory syndrome coronavirus 2 vaccine (procedure) (SNOMED CT Concept 1324691000000104)

      Please click here for a full list of COVID-19 clinical terms available in Vision 3.

      We are currently rolling out a further update which allows these codes to be entered within the immunisation Structured Data Area (SDA). This also includes a change to the name in the immunisation type:

      • COVID-19 – Pfizer/BioNTech (previously Courageous)

      recording_vaccinations_Pfizer_BioNTech

      • COVID-19 – Oxford/AstraZeneca (previously Talent) 

      recording_vaccinations_Oxford_AstraZeneca

      • COVID-19 – Moderna

      image-png-Feb-23-2021-02-44-04-01-PM

      • COVID-19 – Janssen

      image-png-Feb-23-2021-02-44-11-69-PM

      Historical Data Mapping

      As part of the update above, we are retrospectively mapping your existing immunisation and medical history records that currently have 65F0.00 2019- nCov (novel coronavirus) vaccination to the equivalent, stage-specific SNOMED/local Read term. This will be done in two phases:

      • Phase 1 - Update to local vaccination code (currently in progress)
        • 65F0100 2019-nCoV (novel coronavirus) vaccination
        • 65F0200 2019-nCoV (novel coronavirus) vaccination
      • Phase 2 - Update to immunisation code description (to be confirmed)
        • 65F0100 Administration of first dose of severe acute respiratory syndrome coronavirus 2 vaccine (procedure) (SNOMED CT Concept 1324681000000101)
        • 65F0200 Administration of second dose of severe acute respiratory syndrome coronavirus 2 vaccine (procedure) (SNOMED CT Concept 1324691000000104)

      Note - The Coronavirus Clinical Audit includes a reporting line to identify all the immunisations that you have recorded as medical history entries, allowing you to identify and re-enter the data within the immunisation SDA.

      Recording vaccinations as drug items

      • November/December Gemscript - These drug dictionaries contain both the Talent and Courageous vaccines which can be recorded as required from your medication screens.
      • January Gemscript - Delivers changes to the Courageous vaccine drug name updating it to "COVID-19 mRNA Vaccine BNT162b2 30micrograms/0.3ml dose concentrate for suspension for injection multidose vials (Pfizer-BioNTech) (Pfizer-BioNTech)".
      • February Gemscript - Delivers changes to the Talent vaccine drug name updating it to "COVID-19 Vaccine AstraZeneca (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials (AstraZeneca UK Ltd)".

      Recording Adverse Reactions & Allergies

      The following COVID-specific terms are available to record adverse reactions to COVID-19 vaccinations in Vision 3 and Vision Anywhere:

      • TJK62 Adverse reaction to severe acute respiratory syndrome coronavirus 2 vaccine
      • 14L51 Allergy to severe acute respiratory syndrome coronavirus 2 vaccine

      Please see Creating a Yellow Card Report from the Drug Allergy and Intolerance screen.

      Data Entry Templates & Audits